Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision label was updated from v3.3.3 to v3.3.4. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:20:20.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Publications: Lancet 2025 article on Nivolumab added to cisplatin and radiotherapy for high-risk head and neck cancer, and a From PubMed note indicating automatic citation.
    Difference
    0.3%
    Check dated 2025-12-30T21:09:29.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer updates show Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:25:14.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    - The page footer now displays Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:07:05.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page no longer displays the temporary notice about potential data delays due to government funding lapses and where to check operation status (cc.nih.gov; opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:26:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The study page content appears unchanged between the screenshots. No updates to inclusion criteria, primary outcomes, or treatment details are evident.
    Difference
    0.4%
    Check dated 2025-11-03T13:18:47.000Z thumbnail image

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.